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• Majority were cross-sec.onal studies
⎯ Evaluated mul.ple exposures and outcomes
⎯ Generate topics for further research
§ Ethnicity, age, PCOS pathophysiology and severity
• Significant posi.ve rela.onship between AMH and PCOS
• Suggests AMH would be an effec.ve method for evalua.ng PCOM and assist in
the diagnosis of PCOS
• An assessment of study methodology revealed notable limita.ons
⎯ Small sample sizes
§ Ranged between 54 to 997 par.cipants
⎯ Difficulty establishing standard tes.ng protocols
§ Differing AMH threshold values and serum collec.on .melines
• 5 studies evaluated the role of other hormones in PCOS
⎯ LH, FSH, estradiol, and testosterone
⎯ 4 of the 5 studies found some correla.on with AMH
⎯ A consensus on these hormones was difficult to achieve due to these limita.ons
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• Literature search in January 2020
• PubMed and Academic Search Ul.mate
• Search terms: “polycys.c ovarian
syndrome” & “an.-Mullerian Hormone”
& “transvaginal ultrasound”
• 8 ar.cles selected based on relevance
and analyzed for structure and results
• All of the studies reported significant
correla.ons between AMH and PCOS
diagnoses
• Limited sample sizes, recruitment bias,
and tes.ng protocol discrepancies
reduced the external validity of results
• Consistent use of the Romerdam criteria
improved the comparability among
studies
• New studies should include larger
samples with defined study protocols to
improve data collec.on and provide more
compelling results
– Enhanced generalizability of findings
– Establish correla.ons with other PCOS
characteris.cs (other hormonal values)
Polycystic ovarian syndrome (PCOS) is a
complex condition that presents with a wide
variety of symptoms. The PCOS diagnosis
standard is the Rotterdam criteria, which
includes hyperandrogenism, oligo-
anovulation, and polycystic ovarian
morphology (PCOM). Transvaginal
ultrasounds have traditionally been used to
evaluate PCOM, however, they are highly
dependent on technician skill. This paper will
evaluate research regarding the use of anti-
Mullerian hormone (AMH) in PCOS diagnosis
as an alternative to transvaginal ultrasound.
STUDY Serum AMH PCOM Serum Total Testosterone
Ahmed et al (2019) S S N/A
Lie Fong et al (2017) S S N/A
Matsuzaki et al (2017) S S N/A
Nylander et al (2017) S S N/A
Rijal (2019) S S N/A
Safier et al (2016) S S N/A
Wissing et al (2019) S S S
Wongwananuruk et al (2018) S S S
S = significant; NS = not significant
Comparison of Diagnos.c Parameters 
CONCLUSION
• AMH appears to be a valuable tool for
creating an effective diagnostic process
• Study results indicate a significant
relationship between AMH and PCOS
• More research using larger, diverse
samples and detailed testing protocols
are still needed to determine clinical lab
values for AMH
• These studies provide an important
foundation for future research into the
topic of PCOS diagnosis
• With a timely and accurate diagnosis,
women with PCOS would be more likely
to receive appropriate medical screenings
and counseling on disease management
INTRODUCTION
Efficacy of Anti-Mullerian Hormone in the Diagnosis of Polycystic Ovarian Syndrome
• Prevalence of PCOS es.mated between
5–15% of all women
– S.ll frequently overlooked and oren goes
undiagnosed
• Clinical presenta.on can vary significantly
• Essen.ally a diagnosis of exclusion
• Many women visit mul.ple healthcare
providers across numerous special.es
over several years before receiving an
accurate diagnosis
• Delay in diagnosis can impact the overall
quality of life and the ability to effec.vely
manage PCOS
• Notable dissa.sfac.on with the
diagnos.c process
